Galvanize Therapeutics, Inc. — Form D/A
Galvanize Therapeutics, Inc. of Redwood City, CA, a company, filed a Form D amendment with the SEC on 2019-11-18. The offering totals $43.0M, of which $42.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-11-18
- Form: D/A
- Accession: 0001659073-19-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $43.0M
- Amount sold: $42.5M
- Remaining: $485K
- Investors: 1
- Date of first sale: 2015-10-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-334782
Issuer
- Name: Galvanize Therapeutics, Inc.
- CIK: 0001659073
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3200 Bridge Parkway, Redwood City, CA, 94065
- Phone: 650-268-4252
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Doug Godshall | Director | Bloomington, MN |
| Doug Godshall | Executive Officer | Bloomington, MN |
| Jonathan Waldstreicher | Director | Redwood City, CA |
| Jonathan Waldstreicher | Executive Officer | Redwood City, CA |
| Antoine Papiernik | Director | Redwood City, CA |
| David Lewis | Director | BOSTON, MA |
| Steve Anheier | Executive Officer | Redwood City, CA |
| Seth Harrison | Director | Redwood City, CA |
| Zack Scott | Director | Emeryville, CA |
| David McIntyre | Director | Maple Grove, MN |
Other filings by this issuer (4)
More